CN Stock MarketDetailed Quotes
600420 Shanghai Shyndec Pharmaceutical
- 12.26
- -0.43-3.39%
Market Closed Dec 13 15:00 CST
16.44BMarket Cap15.19P/E (TTM)
12.68High12.26Low183.57KlotVolume12.68Open12.69Pre Close227.45MTurnover1.37%Turnover Ratio23.76P/E (Static)1.34BShares14.4152wk High1.26P/B16.44BFloat Cap7.4152wk Low13.96Limit Up1.34BShs Float29.32Historical High11.42Limit Down3.31%Amplitude0.07Historical Low0.20Dividend TTM12.39Avg Price120.23KlotAsk1.63%Div YieldTTM100Lot Size62.21KlotBid
Shanghai Shyndec Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 0.31%5.64B | 11.25%6.45B | 19.30%6.41B | -2.86%5.97B | 28.32%5.62B | 35.40%5.8B | 24.37%5.38B | 43.51%6.15B | 5.03%4.38B | 3.41%4.28B |
| Notes receivable and accounts receivable | -31.69%1.41B | -38.45%1.47B | -38.53%1.53B | -33.60%1.45B | -14.61%2.07B | -17.54%2.38B | -18.67%2.49B | -13.06%2.18B | -10.51%2.42B | -8.36%2.89B |
| -Notes receivable | -46.02%93.66M | -47.42%96.02M | -53.42%143.67M | -63.59%103.47M | -39.02%173.52M | -37.44%182.62M | 43.13%308.4M | 36.92%284.2M | 7.41%284.56M | -4.70%291.92M |
| -Accounts receivable | -30.38%1.32B | -37.71%1.37B | -36.42%1.38B | -29.09%1.34B | -11.35%1.89B | -15.30%2.2B | -23.35%2.18B | -17.58%1.89B | -12.46%2.14B | -8.75%2.6B |
| Other receivables (including interest and dividends) | -2.71%91.4M | 9.35%92.41M | 7.13%92.55M | -9.46%84.07M | 2.47%93.95M | -8.05%84.51M | -4.72%86.39M | -4.19%92.85M | -12.97%91.68M | -12.29%91.9M |
| -Other receivable | ---- | 9.35%92.41M | ---- | ---- | ---- | -8.05%84.51M | ---- | -4.19%92.85M | ---- | -12.29%91.9M |
| Advance payment | -27.63%104.48M | -6.63%151.66M | 27.19%189.02M | -45.60%150.11M | -26.35%144.36M | -29.38%162.42M | -42.12%148.6M | 76.74%275.95M | 7.31%196.02M | 25.68%230M |
| Inventories | -6.97%2.22B | -1.24%2.27B | -4.87%2.35B | -6.53%2.28B | -14.83%2.39B | -24.80%2.3B | -19.63%2.47B | -20.59%2.44B | -16.52%2.8B | -8.44%3.06B |
| Receivable financing | -7.10%292.16M | 11.84%335.36M | 10.89%412.93M | 26.36%605.76M | -42.70%314.49M | -12.51%299.85M | 1.87%372.37M | -11.95%479.39M | 5.05%548.82M | -12.93%342.72M |
| Non-current assets due within one year | --50M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 1,670.58%1.79B | 686.78%619.95M | 303.73%251.17M | 64.96%119.01M | -33.18%101.03M | -67.76%78.8M | -74.87%62.21M | -68.53%72.14M | -30.28%151.21M | 7.53%244.42M |
| Total current assets | 8.10%11.6B | 2.54%11.39B | 2.14%11.24B | -8.79%10.66B | 1.31%10.73B | -0.30%11.11B | -3.60%11B | 7.33%11.68B | -5.94%10.59B | -3.50%11.14B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -1.35%221.87M | -0.33%224.16M | -0.33%224.16M | -0.93%224.16M | -0.60%224.9M | -0.60%224.9M | -0.60%224.9M | 0.00%226.26M | 0.04%226.26M | -0.12%226.26M |
| Investment real estate | -11.75%52.46M | -10.73%54.52M | -11.02%55.73M | -10.07%57.8M | -9.82%59.44M | -9.59%61.08M | -9.47%62.64M | -9.25%64.28M | -9.04%65.91M | -8.88%67.55M |
| Long-term equity investment | 12.28%161.38M | 11.10%160.66M | 3.79%154.37M | 3.70%155.52M | 1.18%143.73M | 0.66%144.61M | 6.19%148.74M | 3.77%149.96M | -1.23%142.06M | -0.54%143.66M |
| Fixed assets | ---- | -7.10%5.45B | ---- | ---- | ---- | 3.35%5.86B | ---- | -5.38%5.51B | ---- | 1.23%5.67B |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | 148.78%601.96K | ---- | --242.37K | ---- | --241.96K |
| Constru in process | ---- | 13.67%154.28M | ---- | ---- | ---- | -76.09%135.72M | ---- | 9.82%641.4M | ---- | -31.04%567.76M |
| Construction materials | ---- | 6.38%1.04M | ---- | ---- | ---- | -33.33%977.06K | ---- | -34.08%966.09K | ---- | -2.34%1.47M |
| Intangible assets | 12.98%556.36M | 12.33%562.23M | 6.70%542.77M | -1.14%511.18M | -6.19%492.45M | -6.30%500.51M | -5.78%508.69M | -5.83%517.08M | 2.39%524.95M | 3.13%534.18M |
| Development expenditure | 4.81%331.35M | 17.97%321.72M | 34.35%316.37M | 40.17%302.94M | 77.30%316.13M | 90.82%272.72M | 79.75%235.48M | 70.50%216.12M | 44.08%178.3M | 20.95%142.92M |
| Goodwill | 0.00%160.15M | 0.00%160.15M | 0.00%160.15M | 0.00%160.15M | 0.00%160.15M | 0.00%160.15M | 0.00%160.15M | 0.00%160.15M | -45.21%160.15M | -45.21%160.15M |
| Long deferred expense | 50.19%40.65M | 33.33%38.23M | 70.19%39.3M | 146.01%28.81M | 115.45%27.07M | 114.32%28.67M | 54.74%23.09M | -34.88%11.71M | -42.75%12.56M | -46.57%13.38M |
| Deferred tax assets | -41.28%133.97M | -36.57%146.06M | -36.46%158.37M | -35.95%153.13M | 16.63%228.13M | 23.22%230.25M | 10.30%249.22M | 26.67%239.09M | 24.01%195.6M | 17.54%186.86M |
| Usufruct assets | -19.18%65.84M | -16.93%70.67M | -16.24%74.27M | -15.61%77.87M | 80.57%81.47M | 77.82%85.07M | 75.30%88.67M | -7.87%92.27M | -58.60%45.12M | -51.28%47.84M |
| Other non current assets | 84.66%1.19B | 813.59%1.24B | 991.89%1.2B | 961.43%1.22B | 195.95%645.02M | -29.99%135.45M | -17.38%109.93M | -39.14%114.65M | 3.64%217.95M | 11.14%193.47M |
| Total non current assets | 1.75%8.47B | 9.36%8.58B | 8.28%8.61B | 9.43%8.7B | 5.22%8.32B | -1.44%7.84B | -1.50%7.96B | -2.90%7.95B | -4.45%7.91B | -3.63%7.96B |
| Total assets | 5.33%20.07B | 5.36%19.97B | 4.72%19.85B | -1.42%19.35B | 2.98%19.05B | -0.77%18.95B | -2.73%18.96B | 2.94%19.63B | -5.31%18.5B | -3.56%19.1B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 11.19%50.09M | -20.00%40.04M | 80.00%45.05M | -85.97%45.05M | -92.63%45.04M | -95.29%50.05M | -98.03%25.03M | -77.17%321.14M | -62.20%611.16M | -35.72%1.06B |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | --3.85M | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | -1.59%1.41B | 5.70%1.47B | 11.16%1.64B | 9.64%1.56B | -13.75%1.44B | -28.62%1.39B | -29.67%1.47B | -16.95%1.42B | -13.15%1.66B | -23.80%1.94B |
| -Notes payable | -4.60%579.66M | 12.11%589.56M | 40.54%627.2M | 31.57%605.49M | -6.25%607.59M | -42.96%525.86M | -45.76%446.28M | -26.06%460.2M | -16.51%648.06M | -26.97%921.93M |
| -Accounts payable | 0.61%833.12M | 1.78%876.38M | -1.60%1.01B | -0.86%953.13M | -18.53%828.08M | -15.68%861.01M | -19.25%1.03B | -11.75%961.38M | -10.85%1.02B | -20.70%1.02B |
| Contract liabilities | 28.98%176.88M | 30.70%138.32M | 23.88%182.94M | -30.31%230.59M | 10.28%137.14M | -38.87%105.83M | 27.68%147.68M | 66.22%330.88M | 33.43%124.35M | 76.85%173.13M |
| Advance receipts | 93.76%5.44M | -9.18%5.47M | 203.84%10.75M | 5.49%14.02M | -27.19%2.81M | 325.73%6.03M | 99.80%3.54M | 513.31%13.29M | 74.28%3.86M | -31.02%1.42M |
| Salaries payable | 28.08%278.05M | 45.04%250.74M | 49.03%195.1M | 21.22%272.81M | 11.35%217.09M | 1.11%172.87M | 1.97%130.92M | -4.55%225.06M | 11.35%194.97M | -3.60%170.97M |
| Taxs payable | 15.47%109.37M | -24.16%76.36M | -10.56%116.13M | -41.98%87.29M | -29.44%94.72M | -25.86%100.68M | -17.75%129.84M | 8.55%150.45M | 16.56%134.24M | 30.47%135.81M |
| Other payable (including interest and dividends) | -2.51%1.53B | -9.97%1.62B | -4.31%1.66B | -5.96%1.53B | -8.84%1.57B | -7.62%1.8B | -4.16%1.73B | -15.75%1.63B | -16.89%1.72B | -0.24%1.95B |
| -Dividend payable | 1.16%2.8M | -97.95%2.8M | 1.16%2.8M | -64.51%2.8M | 4.96%2.77M | 27.12%136.89M | 0.00%2.77M | 185.05%7.89M | -3.61%2.64M | 4,149.22%107.68M |
| -Other payable | ---- | -2.72%1.62B | ---- | ---- | ---- | -9.66%1.66B | ---- | -16.04%1.62B | ---- | -5.64%1.84B |
| Non current liabilities due within one year | 9,538.72%1.03B | 9,850.14%1.02B | 10,030.78%1.02B | -81.79%10.6M | -89.71%10.7M | -90.05%10.29M | -98.32%10.03M | -89.96%58.23M | -83.51%104.03M | -83.56%103.38M |
| Other current liabilities | 17.59%22.77M | 6.27%16.2M | 21.66%25.53M | -38.18%27.6M | -3.15%19.36M | -38.23%15.24M | 20.87%20.99M | -92.95%44.65M | -96.78%19.99M | -96.00%24.68M |
| Total current liabilities | 30.72%4.62B | 27.01%4.64B | 33.01%4.89B | -9.91%3.78B | -22.86%3.53B | -34.37%3.65B | -40.64%3.68B | -38.69%4.2B | -36.77%4.58B | -28.53%5.56B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 683.67%384M | 288.38%384.5M | 136.87%234.5M |
| Bonds payable | ---- | ---- | ---- | -59.91%1.03B | -59.86%1.02B | -59.81%1.02B | 1.36%2.54B | 71.64%2.57B | 71.82%2.55B | 72.01%2.53B |
| Long term salaries pay | -9.22%518.39K | -9.22%518.39K | -9.22%518.39K | -9.22%518.39K | -32.17%571.03K | -32.17%571.03K | -32.17%571.03K | -32.17%571.03K | 22.81%841.8K | 22.81%841.8K |
| Deferred tax liabilities | -31.77%80.23M | -34.79%77M | -81.38%22.14M | -81.47%22.15M | 0.36%117.58M | 0.20%118.08M | -9.54%118.9M | -5.26%119.55M | 44.39%117.16M | 47.76%117.84M |
| Long term deferred income | 3.20%124.24M | -12.34%115.16M | -10.21%119.76M | -11.02%122.8M | -14.14%120.39M | 5.04%131.37M | -0.52%133.37M | -1.66%138.01M | -4.77%140.21M | -14.79%125.06M |
| Lease liabilities | -16.31%49.9M | -14.15%52.79M | -12.78%56.16M | -15.47%57.97M | 174.33%59.63M | 169.36%61.49M | 170.10%64.39M | 59.47%68.57M | -50.14%21.74M | -50.43%22.83M |
| Total non current liabilities | -80.71%254.89M | -81.50%245.47M | -93.04%198.58M | -62.39%1.23B | -58.88%1.32B | -56.17%1.33B | 2.19%2.86B | 76.69%3.28B | 73.22%3.21B | 64.44%3.03B |
| Total liabilities | 0.39%4.87B | -1.92%4.88B | -22.10%5.09B | -32.95%5.01B | -37.71%4.85B | -42.05%4.98B | -27.33%6.53B | -14.05%7.48B | -14.35%7.79B | -10.74%8.59B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.34B | 0.00%1.34B | 14.43%1.34B | 14.43%1.34B | 30.59%1.34B | 30.59%1.34B | 14.13%1.17B | 14.13%1.17B | 0.00%1.03B | 0.00%1.03B |
| Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | -0.01%260.52M | -0.01%260.52M | -0.01%260.52M | -0.01%260.52M |
| Capital reserve funds | 0.00%5.2B | 0.00%5.2B | 45.06%5.2B | 45.06%5.2B | 104.42%5.2B | 104.42%5.2B | 40.93%3.59B | 40.94%3.59B | 0.01%2.55B | 0.01%2.55B |
| Surplus reserve funds | 9.34%438.13M | 9.34%438.13M | 9.34%438.13M | 9.34%438.13M | 19.07%400.7M | 19.07%400.7M | 19.07%400.7M | 19.07%400.7M | 19.49%336.53M | 19.49%336.53M |
| Retained profit | 14.62%6.09B | 17.54%5.99B | 13.28%5.74B | 10.65%5.41B | 11.94%5.32B | 12.09%5.1B | 12.52%5.07B | 10.42%4.89B | 4.52%4.75B | 4.79%4.55B |
| Other composite income | 4.25%-1.2M | 4.23%-1.2M | 10.27%-1.09M | 7.72%-1.09M | -45.40%-1.25M | 26.33%-1.25M | 5.23%-1.21M | 29.71%-1.18M | 31.56%-860.33K | -11.02%-1.7M |
| Shareholders equity without minority interests | 6.64%13.07B | 7.74%12.97B | 21.32%12.72B | 20.21%12.39B | 37.49%12.26B | 38.16%12.04B | 20.93%10.48B | 19.93%10.31B | 3.01%8.92B | 3.11%8.72B |
| Minority interests | 9.38%2.12B | 9.33%2.12B | 5.26%2.04B | 5.55%1.95B | 8.22%1.94B | 7.64%1.94B | 5.93%1.94B | 3.95%1.85B | 0.45%1.79B | 3.81%1.8B |
| Total shareholder equity | 7.02%15.19B | 7.96%15.09B | 18.81%14.76B | 17.98%14.34B | 32.59%14.2B | 32.94%13.98B | 18.32%12.43B | 17.19%12.15B | 2.57%10.71B | 3.23%10.51B |
| Total liabilityies and equity | 5.33%20.07B | 5.36%19.97B | 4.72%19.85B | -1.42%19.35B | 2.98%19.05B | -0.77%18.95B | -2.73%18.96B | 2.94%19.63B | -5.31%18.5B | -3.56%19.1B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
